CALC
CALC
NASDAQ · Pharmaceuticals

Calcimedica Inc

$0.58
-0.16 (-21.68%)
As of Mar 22, 10:59 PM ET ·
Financial Highlights (FY 2025)
Revenue
1.85M
Net Income
558.6K
Gross Margin
50.4%
Profit Margin
30.2%
Rev Growth
+1.8%
D/E Ratio
0.11
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 50.4% 50.4% 50.4%
Operating Margin 29.7% 30.5% 31.5%
Profit Margin 30.2% 26.2% 25.0%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.85M 1.83M 1.75M
Gross Profit 933.2K 920.0K 881.6K
Operating Income 550.0K 556.2K 551.6K
Net Income 558.6K 478.0K 437.1K
Gross Margin 50.4% 50.4% 50.4%
Operating Margin 29.7% 30.5% 31.5%
Profit Margin 30.2% 26.2% 25.0%
Rev Growth +1.8% +20.8% +4.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 637.1K 652.6K 832.4K
Total Equity 5.71M 6.19M 5.86M
D/E Ratio 0.11 0.11 0.14
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 671.1K 736.1K 607.5K
Free Cash Flow 473.4K 406.9K 399.5K